Context Therapeutics Inc. Common Stock

CNTXNASDAQUSD
0.58 USD
0.02 (3.57%)AT CLOSE (11:59 AM EDT)
0.59
0.01 (0.86%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
0.59
0.01 (0.86%)
🔴Market: CLOSED

CNTX is currently priced at $0.58. Technical and fundamental signals converge bearishtechnicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 26, 2026.

Open?$0.57
High?$0.62
Low?$0.56
Prev. Close?$0.56
Volume?14.8M
Avg. Volume?2.7M
VWAP?$0.59
Rel. Volume?5.55x
Bid / Ask
Bid?$0.52 × 100
Ask?$0.69 × 100
Spread?$0.17
Midpoint?$0.60
Valuation & Ratios
Market Cap?53.3M
Shares Out?91.9M
Float?67.5M
Float %?73.5%
P/E Ratio?N/A
P/B Ratio?1.02
EPS?-$0.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Employees
15
Market Cap
51.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-20
Address
2001 MARKET STREET
PHILADELPHIA, PA 19103
Phone: 267-225-7416
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
3
Momentum?
23
Short Sent.?
70
Piotroski F-Score?0/9Weak
Altman Z-Score?0.10Distress
Confidence?44%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.27%Low
Short Interest?854.7K
Days to Cover?1.0
Free Float67.5M
Avg Daily Volume2.4M
Settlement Date2026-06-15
Financial Health
Current Ratio?8.96Strong
Quick Ratio?8.96Strong
Cash Ratio?8.34Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
1.02CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-77.1%WEAK
ROA?
S&P
3
-68.3%WEAK
Cash Flow & Enterprise
FCF?$-32823631
Enterprise Value?$-1238673
Fundamentals ratios updated end of day